These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24864346)

  • 1. Meningococcal disease control in countries of the African meningitis belt, 2013.
    Wkly Epidemiol Rec; 2014 May; 89(20):206-14. PubMed ID: 24864346
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of serogroup A meningococcal conjugate vaccine for Africa.
    Stuart JM
    Hum Vaccin Immunother; 2018 May; 14(5):1116-1117. PubMed ID: 29194010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine introduction. The beginning of the end for Africa's devastating meningitis outbreaks?
    Roberts L
    Science; 2010 Dec; 330(6010):1466-7. PubMed ID: 21148362
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps.
    LaForce FM; Djingarey M; Viviani S; Preziosi MP
    Hum Vaccin Immunother; 2018 May; 14(5):1098-1102. PubMed ID: 28968148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemic meningitis control in countries of the African meningitis belt, 2016.
    Wkly Epidemiol Rec; 2017 Mar; 92(13):145-54. PubMed ID: 28361528
    [No Abstract]   [Full Text] [Related]  

  • 6. Meningococcal meningitis: vaccination outbreak response and epidemiological changes in the African meningitis belt.
    Carod Artal FJ
    Int Health; 2015 Jul; 7(4):226-7. PubMed ID: 25878213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eliminating Meningococcal Epidemics From the African Meningitis Belt: The Case for Advanced Prevention and Control Using Next-Generation Meningococcal Conjugate Vaccines.
    Alderson MR; LaForce FM; Sobanjo-Ter Meulen A; Hwang A; Preziosi MP; Klugman KP
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S274-S278. PubMed ID: 31671447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Changing Epidemiology of Meningococcal Disease.
    Cohn A; MacNeil J
    Infect Dis Clin North Am; 2015 Dec; 29(4):667-77. PubMed ID: 26610420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningococcal carriage in the African meningitis belt.
    MenAfriCar Consortium
    Trop Med Int Health; 2013 Aug; 18(8):968-78. PubMed ID: 23682910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meningococcal carriage by age in the African meningitis belt: a systematic review and meta-analysis.
    Cooper LV; Kristiansen PA; Christensen H; Karachaliou A; Trotter CL
    Epidemiol Infect; 2019 Jan; 147():e228. PubMed ID: 31364554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal disease in countries of the African meningitis belt, 2012 - emerging needs and future perspectives.
    Wkly Epidemiol Rec; 2013 Mar; 88(12):129-36. PubMed ID: 23544241
    [No Abstract]   [Full Text] [Related]  

  • 12. Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution.
    Marc LaForce F; Ravenscroft N; Djingarey M; Viviani S
    Vaccine; 2009 Jun; 27 Suppl 2():B13-9. PubMed ID: 19477559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges.
    Mustapha MM; Harrison LH
    Hum Vaccin Immunother; 2018 May; 14(5):1107-1115. PubMed ID: 29211624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward a meningitis-free world.
    Black S; Pizza M; Nissum M; Rappuoli R
    Sci Transl Med; 2012 Feb; 4(123):123ps5. PubMed ID: 22378923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of emerging vaccines for childhood meningococcal disease.
    Choudhuri D; Huda T; Theodoratou E; Nair H; Zgaga L; Falconer R; Luksic I; Johnson HL; Zhang JS; El Arifeen S; Nelson CB; Borrow R; Campbell H; Rudan I
    BMC Public Health; 2011 Apr; 11 Suppl 3(Suppl 3):S29. PubMed ID: 21501447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal childhood immunisation with pneumococcal vaccine and meningococcal serogroup C vaccine introduced in Germany.
    Wiese-Posselt M; Hellenbrand W; Siedler A; Mayer C
    Euro Surveill; 2006 Sep; 11(9):E060907.4. PubMed ID: 17075143
    [No Abstract]   [Full Text] [Related]  

  • 17. Meningococcal vaccine in travelers.
    Wilder-Smith A
    Curr Opin Infect Dis; 2007 Oct; 20(5):454-60. PubMed ID: 17762777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neisseria meningitidis serogroup A vaccines: an overview.
    Vergnano S; Heath P
    Expert Rev Vaccines; 2003 Aug; 2(4):571-82. PubMed ID: 14711341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Narrative review of methods and findings of recent studies on the carriage of meningococci and other Neisseria species in the African Meningitis Belt.
    Greenwood BM; Aseffa A; Caugant DA; Diallo K; Kristiansen PA; Maiden MCJ; Stuart JM; Trotter CL
    Trop Med Int Health; 2019 Feb; 24(2):143-154. PubMed ID: 30461138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A vaccine to prevent epidemic meningitis in Africa.
    Viviani S
    Lancet Infect Dis; 2013 Mar; 13(3):195-6. PubMed ID: 23427886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.